The trajectory of Sildenafil presents a intricate picture for investors. While the initial introduction generated significant gains, the expiration of its exclusive rights opened the door to cheaper competitors, https://bookmarkspiral.com/story21639486/sildenafil-and-the-pharmaceutical-industry-a-risky-bet